ArticleOncology2026

Serum MicroRNA-122 Predicts Early Progressive Disease in Unresectable Hepatocellular Carcinoma with Atezolizumab plus Bevacizumab Therapy.

Shigeki Yamamoto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.